Home › Companies › VERVE THERAPEUTICS INC. › 2023-2024
Compiled from SEC Form N-PX filings and VERVE THERAPEUTICS INC.’s Form 8-K, filed June 7, 2024 (Item 5.07 on EDGAR). Page generated November 1, 2026.
Meeting of June 6, 2024: 4 items on VERVE THERAPEUTICS INC.’s Form 8-K, filed June 7, 2024: 2 approved · 2 without a stated outcome.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2023-2024 2024-2025
Explore VERVE THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are VERVE THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 7, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Burt Adelman, M.D. | 27,760,743 | -- | -- | 17,141,076 | 24,032,475 | 62% | Not verified | — |
| Elect Director: Sekar Kathiresan, M.D. | 44,455,131 | -- | -- | 448,061 | 24,031,102 | 99.0% | Not verified | — |
| 2. Ratification of Appointment of the Company's Independent Registered Public Accounting Firm | 68,752,292 | 76,802 | 105,200 | -- | 0 | 99.8% | Approved | — |
| 3. Approval, on an Advisory Basis, of Compensation Paid to Company's Named Executive Officers | 39,396,050 | 5,481,524 | 25,644 | -- | 24,031,076 | 88% | Approved | — |
Source: VERVE THERAPEUTICS INC., Form 8-K, filed with the SEC on June 7, 2024 — read the filing on EDGAR.
Each item below shows how the 195 asset managers that disclosed a VERVE THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of VERVE THERAPEUTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 3 wordings of this item as funds reported it.
62% Majority: yes · of votes cast
Description as filed by funds: Election of two Class III directors to our board of directors, each to serve until the 2027 annual meeting of stockholders: Burt Adelman, M.D.
VERVE THERAPEUTICS INC.’s own tally for this item (“Elect Director: Burt Adelman, M.D.”): 27,760,743 for, 17,141,076 withheld, per its Form 8-K filed June 7, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 62% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 54 asset managers below reported 17,213,253 for, 5,618,771 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 5,835,530 | 0 | 0 | 0 | For |
| Vanguard | 5,734,144 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,576,896 | 0 | 0 | 0 | For |
| Federated Hermes | 2,386,671 | 0 | 0 | 0 | For |
| State Street | 17,088 | 0 | 0 | 1,613,519 | Withhold |
| BlackRock | 0 | 0 | 0 | 1,007,922 | Withhold |
| TIAA | 0 | 0 | 0 | 824,412 | Withhold |
| Charles Schwab | 0 | 0 | 0 | 489,689 | Withhold |
| Goldman Sachs | 0 | 0 | 0 | 271,088 | Withhold |
| Dimensional | 0 | 0 | 0 | 263,980 | Withhold |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 244,044 | Withhold |
| JPMorgan | 194,550 | 0 | 0 | 0 | For |
| Fidelity | 165,908 | 0 | 0 | 25,307 | Mixed |
| AIG/SunAmerica | 0 | 0 | 0 | 127,470 | Withhold |
| AMERICAN BEACON FUNDS | 98,051 | 0 | 0 | 0 | For |
| Global X | 0 | 0 | 0 | 93,525 | Withhold |
| Equitable | 0 | 0 | 0 | 83,520 | Withhold |
| ProShares | 0 | 0 | 0 | 80,371 | Withhold |
| American Century | 0 | 0 | 0 | 80,356 | Withhold |
| Columbia Threadneedle | 0 | 0 | 0 | 74,020 | Withhold |
| Lincoln Financial | 0 | 0 | 0 | 70,624 | Withhold |
| Northwestern Mutual | 70,453 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 0 | 0 | 51,959 | Withhold |
| Nushares ETF Trust | 0 | 0 | 0 | 51,469 | Withhold |
| TARGET PORTFOLIO TRUST | 44,600 | 0 | 0 | 0 | For |
Showing the 25 largest of 54 asset managers. See all 54 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.0% Majority: yes · of votes cast
Description as filed by funds: Election of two Class III directors to our board of directors, each to serve until the 2027 annual meeting of stockholders: Sekar Kathiresan, M.D.
VERVE THERAPEUTICS INC.’s own tally for this item (“Elect Director: Sekar Kathiresan, M.D.”): 44,455,131 for, 448,061 withheld, per its Form 8-K filed June 7, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.0% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 54 asset managers below reported 22,563,249 for, 268,775 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 5,835,530 | 0 | 0 | 0 | For |
| Vanguard | 5,734,144 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,576,896 | 0 | 0 | 0 | For |
| Federated Hermes | 2,386,671 | 0 | 0 | 0 | For |
| State Street | 1,628,834 | 0 | 0 | 1,773 | For |
| BlackRock | 1,007,922 | 0 | 0 | 0 | For |
| TIAA | 824,412 | 0 | 0 | 0 | For |
| Charles Schwab | 489,689 | 0 | 0 | 0 | For |
| Goldman Sachs | 271,088 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 263,980 | Withhold |
| Direxion Shares ETF Trust | 244,044 | 0 | 0 | 0 | For |
| JPMorgan | 194,550 | 0 | 0 | 0 | For |
| Fidelity | 191,215 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 127,470 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 98,051 | 0 | 0 | 0 | For |
| Global X | 93,525 | 0 | 0 | 0 | For |
| Equitable | 83,520 | 0 | 0 | 0 | For |
| ProShares | 80,371 | 0 | 0 | 0 | For |
| American Century | 80,356 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 74,020 | 0 | 0 | 0 | For |
| Lincoln Financial | 68,948 | 0 | 0 | 1,676 | For |
| Northwestern Mutual | 70,453 | 0 | 0 | 0 | For |
| Northern Trust | 51,959 | 0 | 0 | 0 | For |
| Nushares ETF Trust | 51,469 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 44,600 | 0 | 0 | 0 | For |
Showing the 25 largest of 54 asset managers. See all 54 in the interactive database.
Combines 6 wordings of this item as funds reported it.
88% Approved · of votes cast
Description as filed by funds: APPROVAL, ON AN ADVISORY BASIS, OF THE COMPENSATION PAID TO OUR NAMED EXECUTIVE OFFICERS.
VERVE THERAPEUTICS INC.’s own tally for this item (“3. Approval, on an Advisory Basis, of Compensation Paid to Company's Named Executive Officers”): 39,396,050 for, 5,481,524 against — passed, per its Form 8-K filed June 7, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 3 – Approval, on an Advisory Basis, of Compensation Paid to Company's Named Executive Officers The stockholders of the Company approved, on an advisory basis, the compensation paid to its named executive officers.”
Support: 88% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 5,835,530 | 0 | 0 | 0 | For |
| Vanguard | 5,734,144 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,576,896 | 0 | 0 | 0 | For |
| Federated Hermes | 2,386,671 | 0 | 0 | 0 | For |
| State Street | 1,626,812 | 3,795 | 0 | 0 | For |
| BlackRock | 0 | 1,007,922 | 0 | 0 | Against |
| TIAA | 824,412 | 0 | 0 | 0 | For |
| Charles Schwab | 489,689 | 0 | 0 | 0 | For |
| Goldman Sachs | 271,088 | 0 | 0 | 0 | For |
| Dimensional | 0 | 263,980 | 0 | 0 | Against |
| Direxion Shares ETF Trust | 244,044 | 0 | 0 | 0 | For |
| JPMorgan | 194,550 | 0 | 0 | 0 | For |
| Fidelity | 165,908 | 25,307 | 0 | 0 | Mixed |
| AIG/SunAmerica | 127,470 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 98,051 | 0 | 0 | 0 | For |
| Global X | 0 | 93,525 | 0 | 0 | Against |
| Equitable | 63,610 | 19,910 | 0 | 0 | Mixed |
| ProShares | 80,371 | 0 | 0 | 0 | For |
| American Century | 0 | 80,356 | 0 | 0 | Against |
| Columbia Threadneedle | 74,020 | 0 | 0 | 0 | For |
| Lincoln Financial | 68,948 | 1,676 | 0 | 0 | For |
| Northwestern Mutual | 70,453 | 0 | 0 | 0 | For |
| Northern Trust | 51,959 | 0 | 0 | 0 | For |
| Nushares ETF Trust | 51,469 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 0 | 44,600 | 0 | 0 | Against |
Fund voting reports, all 55 managers: 21,227,745 for, 1,638,763 against. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BVF INC/IL | 6,500,000 | 0 | 0 | 0 | For |
| T. Rowe Price | 4,316,054 | 0 | 0 | 0 | For |
| State Street | 2,710,463 | 3,821 | 0 | 0 | For |
| Federated Hermes | 2,386,671 | 0 | 0 | 0 | For |
| Nikko Asset Management Americas, Inc. | 2,169,714 | 0 | 0 | 0 | For |
| Novo Holdings A/S | 2,000,000 | 0 | 0 | 0 | For |
| Redmile Group, LLC | 0 | 1,604,515 | 0 | 0 | Against |
| BlackRock | 19,438 | 1,448,704 | 0 | 0 | Against |
| EcoR1 Capital, LLC | 1,250,000 | 0 | 0 | 0 | For |
| Nuveen | 880,996 | 0 | 0 | 0 | For |
| JPMorgan | 665,487 | 0 | 0 | 0 | For |
| MPM BioImpact LLC | 638,163 | 0 | 0 | 0 | For |
| Palo Alto Investors LP | 575,517 | 0 | 0 | 0 | For |
| Woodline Partners LP | 521,157 | 0 | 0 | 0 | For |
| Charles Schwab | 489,689 | 0 | 0 | 0 | For |
| Nikko Asset Management Co., Ltd. | 445,478 | 0 | 0 | 0 | For |
| Cormorant Asset Management, LP | 350,000 | 0 | 0 | 0 | For |
| Northern Trust | 322,472 | 1,989 | 0 | 0 | For |
| Fidelity | 321,468 | 0 | 0 | 0 | For |
| Citadel | 291,067 | 0 | 0 | 0 | For |
| Impresa Management LLC | 247,153 | 0 | 0 | 0 | For |
| Rafferty Asset Management, LLC | 244,044 | 0 | 0 | 0 | For |
| Wellington | 0 | 213,339 | 0 | 0 | Against |
| Two Sigma | 188,069 | 0 | 0 | 0 | For |
| STIFEL NICOLAUS & CO INC \MO\ | 125,928 | 0 | 0 | 0 | For |
Institutional-manager reports, all 153 managers: 28,484,063 for, 3,889,324 against, 114 abstained, 32,952 1 year. Showing the 25 largest; see all in the interactive database.
Combines 2 wordings of this item as funds reported it.
99.9% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: APPROVAL, ON AN ADVISORY BASIS, OF THE FREQUENCY OF FUTURE ADVISORY VOTES ON THE COMPENSATION PAID TO OUR NAMED EXECUTIVE OFFICERS.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 0 | 0 | 0 | 0 | -- |
| Vanguard | 0 | 0 | 0 | 0 | -- |
| T. Rowe Price | 0 | 0 | 0 | 0 | -- |
| Federated Hermes | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| TIAA | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| Goldman Sachs | 0 | 0 | 0 | 0 | -- |
| Dimensional | 0 | 0 | 0 | 0 | -- |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 0 | -- |
| JPMorgan | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| AIG/SunAmerica | 0 | 0 | 0 | 0 | -- |
| AMERICAN BEACON FUNDS | 0 | 0 | 0 | 0 | -- |
| Global X | 0 | 0 | 0 | 0 | -- |
| Equitable | 0 | 0 | 0 | 0 | -- |
| ProShares | 0 | 0 | 0 | 0 | -- |
| American Century | 0 | 0 | 0 | 0 | -- |
| Columbia Threadneedle | 0 | 0 | 0 | 0 | -- |
| Lincoln Financial | 0 | 0 | 0 | 0 | -- |
| Northwestern Mutual | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| Nushares ETF Trust | 0 | 0 | 0 | 0 | -- |
| TARGET PORTFOLIO TRUST | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 54 managers: 22,565,022 1 year, 267,002 3 year. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BVF INC/IL | 0 | 0 | 0 | 0 | -- |
| T. Rowe Price | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| Federated Hermes | 0 | 0 | 0 | 0 | -- |
| Nikko Asset Management Americas, Inc. | 0 | 0 | 0 | 0 | -- |
| Novo Holdings A/S | 0 | 0 | 0 | 0 | -- |
| Redmile Group, LLC | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| Nuveen | 0 | 0 | 0 | 0 | -- |
| MPM BioImpact LLC | 0 | 0 | 0 | 0 | -- |
| Palo Alto Investors LP | 0 | 0 | 0 | 0 | -- |
| Woodline Partners LP | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| Nikko Asset Management Co., Ltd. | 0 | 0 | 0 | 0 | -- |
| Cormorant Asset Management, LP | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| Citadel | 0 | 0 | 0 | 0 | -- |
| Rafferty Asset Management, LLC | 0 | 0 | 0 | 0 | -- |
| Wellington | 0 | 0 | 0 | 0 | -- |
| Two Sigma | 0 | 0 | 0 | 0 | -- |
| STIFEL NICOLAUS & CO INC \MO\ | 0 | 0 | 0 | 0 | -- |
| MELLON INVESTMENTS Corp | 0 | 0 | 0 | 0 | -- |
| Vestmark Advisory Solutions, Inc. | 0 | 0 | 0 | 0 | -- |
| Goldman Sachs | 0 | 0 | 0 | 0 | -- |
Institutional-manager reports, all 144 managers: 34,437 for, 30 against, 30,184,308 1 year, 55,007 3 year, 1,000 2 year, 540 unknown. Showing the 25 largest; see all in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.8% Approved · of votes cast
Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2024.
VERVE THERAPEUTICS INC.’s own tally for this item (“2. Ratification of Appointment of the Company's Independent Registered Public Accounting Firm”): 68,752,292 for, 76,802 against — passed, per its Form 8-K filed June 7, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 2 – Ratification of Appointment of the Company's Independent Registered Public Accounting Firm The stockholders of the Company ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 55 asset managers below reported 22,866,508 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARK ETF Trust | 5,835,530 | 0 | 0 | 0 | For |
| Vanguard | 5,734,144 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,576,896 | 0 | 0 | 0 | For |
| Federated Hermes | 2,386,671 | 0 | 0 | 0 | For |
| State Street | 1,630,607 | 0 | 0 | 0 | For |
| BlackRock | 1,007,922 | 0 | 0 | 0 | For |
| TIAA | 824,412 | 0 | 0 | 0 | For |
| Charles Schwab | 489,689 | 0 | 0 | 0 | For |
| Goldman Sachs | 271,088 | 0 | 0 | 0 | For |
| Dimensional | 263,980 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 244,044 | 0 | 0 | 0 | For |
| JPMorgan | 194,550 | 0 | 0 | 0 | For |
| Fidelity | 191,215 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 127,470 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 98,051 | 0 | 0 | 0 | For |
| Global X | 93,525 | 0 | 0 | 0 | For |
| Equitable | 83,520 | 0 | 0 | 0 | For |
| ProShares | 80,371 | 0 | 0 | 0 | For |
| American Century | 80,356 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 74,020 | 0 | 0 | 0 | For |
| Lincoln Financial | 70,624 | 0 | 0 | 0 | For |
| Northwestern Mutual | 70,453 | 0 | 0 | 0 | For |
| Northern Trust | 51,959 | 0 | 0 | 0 | For |
| Nushares ETF Trust | 51,469 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 44,600 | 0 | 0 | 0 | For |
Showing the 25 largest of 55 asset managers. See all 55 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported.
| # | Asset manager | Shares voted |
|---|---|---|
| 1 | ARK ETF Trust | 5,835,530 |
| 2 | Vanguard | 5,734,144 |
| 3 | T. Rowe Price | 2,576,896 |
| 4 | Federated Hermes | 2,386,671 |
| 5 | State Street | 1,630,607 |
| 6 | BlackRock | 1,007,922 |
| 7 | TIAA | 824,412 |
| 8 | Charles Schwab | 489,689 |
| 9 | Goldman Sachs | 271,088 |
| 10 | Dimensional | 263,980 |
| # | Asset manager | Shares voted |
|---|---|---|
| 1 | BVF INC/IL | 6,500,000 |
| 2 | T. Rowe Price | 4,316,054 |
| 3 | State Street | 2,714,284 |
| 4 | Federated Hermes | 2,386,671 |
| 5 | Nikko Asset Management Americas, Inc. | 2,169,714 |
| 6 | Novo Holdings A/S | 2,000,000 |
| 7 | Redmile Group, LLC | 1,604,515 |
| 8 | BlackRock | 1,468,142 |
| 9 | EcoR1 Capital, LLC | 1,250,000 |
| 10 | Nuveen | 880,996 |
Shown as share counts, not percentages: no shares-outstanding figure has been matched to VERVE THERAPEUTICS INC. for the 2023-2024 season, so there is no denominator to divide by.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. This page is a static snapshot rebuilt weekly on November 1, 2026; a live search always shows the current data.
At VERVE THERAPEUTICS INC.'s shareholder meeting held June 6, 2024, in the 2023-2024 proxy season, 195 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,368 separate fund positions. Their filings are grouped here into 5 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — APPROVAL, ON AN ADVISORY BASIS, OF THE COMPENSATION PAID TO OUR NAMED EXECUTIVE OFFICERS. — VERVE THERAPEUTICS INC.'s filing reports the proposal as approved, with 88% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: VERVE THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 7, 2024.
VERVE THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025.
Download data (CSV): ballot items · votes by manager · column guide.